Literature DB >> 9916075

Early resistance of interleukin-10 knockout mice to acute systemic candidiasis.

A Vazquez-Torres1, J Jones-Carson, R D Wagner, T Warner, E Balish.   

Abstract

In contrast to immunocompetent controls, interleukin-10 (IL-10) knockout (KO) mice eliminated an experimental intravenous inoculation with Candida albicans from their kidneys. Improved clearance of C. albicans from the kidneys of IL-10 KO mice was evident at 24 h after intravenous challenge with the fungus. Conversely, mice with a deletion of the IL-4 cytokine gene were more susceptible to systemic candidiasis than were immunocompetent controls. The hyperresistance of IL-10 KO mice to acute systemic candidiasis did not seem to correlate with nitric oxide-mediated immunity, but rather, it appeared to be associated with more efficient effector function of innate cells, possibly neutrophils. In support of the latter hypothesis, we observed that neutrophils from IL-10 KO mice were more efficient at killing C. albicans blastoconidia and hyphae than were neutrophils from immunocompetent control mice. Neither IL-10 KO nor IL-4 KO mice that were monoassociated with C. albicans for 4 weeks showed any histologic evidence of systemic candidiasis of endogenous origin. In contrast to systemic candidiasis, we observed no significant (P < 0.05) differences in susceptibility among IL-10 KO, IL-4 KO, and wild-type (immunocompetent) mice to orogastric candidiasis. Our results suggest that IL-10 exerts a negative effect on the early, innate response to acute systemic candidiasis; however, in comparison to immunocompetent control (wild-type) mice, neither IL-10 nor IL-4 deficiency enhanced susceptibility to orogastric candidiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916075      PMCID: PMC96371     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.

Authors:  M K Hostetter
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

2.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

3.  Candidiasis in the transplant patient.

Authors:  R A Clift
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

4.  Nitric oxide enhances resistance of SCID mice to mucosal candidiasis.

Authors:  A Vazquez-Torres; J Jones-Carson; T Warner; E Balish
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

5.  Systemic candidiasis in cancer patients.

Authors:  A W Maksymiuk; S Thongprasert; R Hopfer; M Luna; V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

6.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

7.  Defective killing of Candida albicans hyphae by neutrophils from beige mice.

Authors:  J Jones-Carson; A Vazquez-Torres; E Balish
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

8.  Interleukin-4 and -10 exacerbate candidiasis in mice.

Authors:  L Tonnetti; R Spaccapelo; E Cenci; A Mencacci; P Puccetti; R L Coffman; F Bistoni; L Romani
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

9.  Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans.

Authors:  A P Burford-Mason; R C Matthews; J R Williams
Journal:  J Infect       Date:  1987-03       Impact factor: 6.072

10.  Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.

Authors:  L Romani; A Mencacci; U Grohmann; S Mocci; P Mosci; P Puccetti; F Bistoni
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  34 in total

1.  Increased susceptibility to Candida infection following cecal ligation and puncture.

Authors:  Christopher G Davis; Kathy Chang; Dale Osborne; Andrew H Walton; W Michael Dunne; Jared T Muenzer
Journal:  Biochem Biophys Res Commun       Date:  2011-09-12       Impact factor: 3.575

2.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

4.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Candida and invasive candidiasis: back to basics.

Authors:  C S-Y Lim; R Rosli; H F Seow; P P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

6.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Authors:  Seagal Teitz-Tennenbaum; Steven P Viglianti; Jonathan A Roussey; Stuart M Levitz; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

Review 7.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

Review 8.  IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Authors:  Robert B Ashman; Dipti Vijayan; Christine A Wells
Journal:  Clin Dev Immunol       Date:  2010-11-01

9.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

10.  Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection.

Authors:  Marcela R Camargo; James Venturini; Fátima R Vilani-Moreno; Maria Sueli P Arruda
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.